Xenon Pharmaceuticals Inc... (XENE)
NASDAQ: XENE
· Real-Time Price · USD
32.85
0.65 (2.02%)
At close: Jun 27, 2025, 12:40 PM
2.02% (1D)
| Bid | 23.31 |
| Market Cap | 2.52B |
| Revenue (ttm) | 7.5M |
| Net Income (ttm) | -251.45M |
| EPS (ttm) | -3.22 |
| PE Ratio (ttm) | -10.2 |
| Forward PE | -7.23 |
| Analyst | Buy |
| Ask | 41.16 |
| Volume | 502,651 |
| Avg. Volume (20D) | 1,073,833 |
| Open | 32.35 |
| Previous Close | 32.20 |
| Day's Range | 32.02 - 32.99 |
| 52-Week Range | 26.74 - 46.00 |
| Beta | 1.10 |
About XENE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol XENE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for XENE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-17.43%
Xenon Pharmaceuticals shares are trading lower. Th...
Unlock content with
Pro Subscription
1 month ago
+2.37%
Xenon Pharmaceuticals shares are trading lower. The company reported Q1 financial results.
1 month ago · proactiveinvestors.co.uk
Polarean's Xenon MRI technology to feature in over 30 studies at American Thoracic Society eventsPolarean Imaging PLC (AIM:POLX, OTC:PLLWF), the AIM-listed medical imaging company, will have its Xenon-based magnetic resonance imaging (MRI) technology showcased in more than 30 clinical studies at ...
1 month ago · seekingalpha.com
Xenon Pharmaceuticals Inc. (XENE) Q1 2025 Earnings Call TranscriptXenon Pharmaceuticals Inc. (NASDAQ:XENE ) Q1 2025 Earnings Conference Call May 12, 2025 4:30 AM ET Corporate Participants Chad Fugere - Vice President, Investor Relations Ian Mortimer - President and ...
